Compounds > bazedoxifene
Page last updated: 2024-09-04

bazedoxifene and ly 353381

bazedoxifene has been researched along with ly 353381 in 5 studies

Compound Research Comparison

Studies
(bazedoxifene)		Trials
(bazedoxifene)		Recent Studies (post-2010)
(bazedoxifene)		Studies
(ly 353381)		Trials
(ly 353381)		Recent Studies (post-2010) (ly 353381)
30769249701215

Protein Interaction Comparison

ProteinTaxonomybazedoxifene (IC50)ly 353381 (IC50)
Estrogen receptorHomo sapiens (human)0.0378
Estrogen receptor betaHomo sapiens (human)0.0985

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohta, H1
Lewiecki, EM1
Silverman, SL1
Chines, AA; Komm, BS1
Calaf Alsina, J; Coronado Martín, PJ1

Reviews

5 review(s) available for bazedoxifene and ly 353381

ArticleYear
[Status of novel bone-targeting SERMs in development].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Nov-28, Volume: 65 Suppl 9

    Topics: Animals; Bone and Bones; Bone Density; Clinical Trials as Topic; Drug Design; Humans; Indoles; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Receptors, Estrogen; Research; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Thiophenes

2007
Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
    Journal of women's health (2002), 2009, Volume: 18, Issue:10

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Drug Therapy, Combination; Female; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Piperidines; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; RANK Ligand; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Vitamin D; Women's Health

2009
New selective estrogen receptor modulators (SERMs) in development.
    Current osteoporosis reports, 2010, Volume: 8, Issue:3

    Topics: Bone Density Conservation Agents; Breast Neoplasms; Female; Humans; Indoles; Osteoporosis; Piperidines; Pyrrolidines; Risk Factors; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Thiophenes

2010
An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis.
    Maturitas, 2012, Volume: 71, Issue:3

    Topics: Bone Density Conservation Agents; Breast; Endometrium; Female; Fractures, Bone; Humans; Indoles; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes

2012
[Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action].
    Medicina clinica, 2013, Mar-16, Volume: 140, Issue:6

    Topics: Adenocarcinoma; Animals; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Organ Specificity; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Thromboembolism

2013